Sabra Health Care REIT, Inc.
SBRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $703 | $648 | $625 | $570 |
| % Growth | 8.6% | 3.6% | 9.7% | – |
| Cost of Goods Sold | $227 | $195 | $163 | $141 |
| Gross Profit | $476 | $452 | $462 | $428 |
| % Margin | 67.7% | 69.8% | 74% | 75.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $50 | $47 | $40 | $35 |
| SG&A Expenses | $50 | $47 | $40 | $35 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $169 | $183 | $188 | $183 |
| Operating Expenses | $219 | $231 | $227 | $218 |
| Operating Income | $257 | $222 | $235 | $211 |
| % Margin | 36.5% | 34.2% | 37.6% | 37% |
| Other Income/Exp. Net | -$129 | -$206 | -$311 | -$322 |
| Pre-Tax Income | $128 | $16 | -$76 | -$111 |
| Tax Expense | $1 | $2 | $1 | $2 |
| Net Income | $127 | $14 | -$78 | -$113 |
| % Margin | 18% | 2.1% | -12.4% | -19.9% |
| EPS | 0.54 | 0.06 | -0.34 | -0.52 |
| % Growth | 807.6% | 117.5% | 34.6% | – |
| EPS Diluted | 0.54 | 0.059 | -0.34 | -0.52 |
| Weighted Avg Shares Out | 233 | 231 | 231 | 219 |
| Weighted Avg Shares Out Dil | 236 | 233 | 231 | 219 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $115 | $113 | $105 | $99 |
| Depreciation & Amortization | $170 | $183 | $188 | $179 |
| EBITDA | $413 | $312 | $217 | $166 |
| % Margin | 58.7% | 48.2% | 34.7% | 29.2% |